Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Its low valuation, with P/E ratio at 5.91 and 8.28 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● This company will be of major interest to investors in search of a high dividend stock.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Over the past four months, analysts' average price target has been revised upwards significantly.

● The opinion of analysts covering the stock has improved over the past four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● The company's earnings growth outlook lacks momentum and is a weakness.